Seek Returns logo

ASND vs. BDX: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ASND and BDX, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.

Company Overview

BDX stands out with 49.62 billion USD in market value—about 5.20× ASND’s market cap of 9.55 billion USD.

With betas of 0.40 for ASND and 0.34 for BDX, both show similar volatility profiles relative to the overall market.

ASND trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while BDX remains a standard domestic listing.

SymbolASNDBDX
Company NameAscendis Pharma A/SBecton, Dickinson and Company
CountryDKUS
SectorHealthcareHealthcare
IndustryBiotechnologyMedical - Instruments & Supplies
CEOMr. Jan Moller MikkelsenMr. Thomas E. Polen Jr.
Price158.1 USD173.14 USD
Market Cap9.55 billion USD49.62 billion USD
Beta0.400.34
ExchangeNASDAQNYSE
IPO DateJanuary 28, 2015February 21, 1973
ADRYesNo

Performance Comparison

This chart compares the performance of ASND and BDX over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of ASND and BDX based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

  • ASND posts a negative P/E of -24.55, reflecting last year’s net loss, while BDX at 33.33 signals healthy earnings.
  • ASND posts a negative forward PEG of -2.23, hinting at anticipated earnings decline, whereas BDX at 5.92 has projections for stable or growing earnings.
  • ASND has a negative P/B ratio of -44.20, indicating its liabilities exceed assets (negative equity). BDX, with a P/B of 1.98, maintains positive shareholder equity.
  • ASND has a negative Price-to-Free Cash Flow ratio of -27.43, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, BDX (P/FCF 19.16) indicates positive free cash flow generation.
SymbolASNDBDX
Price-to-Earnings Ratio (P/E, TTM)-24.5533.33
Forward PEG Ratio (TTM)-2.235.92
Price-to-Sales Ratio (P/S, TTM)22.892.38
Price-to-Book Ratio (P/B, TTM)-44.201.98
Price-to-Free Cash Flow Ratio (P/FCF, TTM)-27.4319.16
EV-to-EBITDA (TTM)-35.7419.40
EV-to-Sales (TTM)23.783.27
EV-to-Free Cash Flow (TTM)-28.5026.34

Dividend Comparison

ASND offers a 0% dividend yield, suggesting it may be reinvesting available cash back into the business for future growth, while BDX provides a 2.30% dividend yield, giving investors a steady income stream.

SymbolASNDBDX
Dividend Yield (TTM)0.00%2.30%

Financial Strength Metrics Comparison

This section dives into the financial resilience of ASND and BDX, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

  • Both ASND (quick ratio 0.71) and BDX (quick ratio 0.64) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
  • ASND has negative equity (debt-to-equity ratio -4.46), an unusual warning sign, while BDX at 0.76 maintains a conventional debt-to-equity balance.
  • With negative EBIT (-3.72), ASND cannot cover its interest payments. BDX, with an interest coverage of 3.95, meets its interest obligations.
SymbolASNDBDX
Current Ratio (TTM)1.041.13
Quick Ratio (TTM)0.710.64
Debt-to-Equity Ratio (TTM)-4.460.76
Debt-to-Assets Ratio (TTM)0.800.35
Interest Coverage Ratio (TTM)-3.723.95